» Articles » PMID: 11333844

Amino Acid Kinetics in Patients with Sepsis

Overview
Journal Am J Clin Nutr
Publisher Elsevier
Date 2001 May 3
PMID 11333844
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In patients with sepsis and systemic inflammatory response syndrome, amino acid extraction by the liver is enhanced, resulting in decreased plasma amino acid concentrations. Systematic investigations of the elimination of intravenously infused amino acids have not been performed.

Objective: The objective of this study was to compare the elimination of 17 amino acids in patients with sepsis and in healthy control subjects.

Design: Elimination of amino acids was evaluated in 9 patients with sepsis and in 8 healthy control subjects by using a combined loading and maintenance infusion of 375 mg amino acids/kg body wt for 60 min. Pharmacokinetic variables were analyzed from plasma curves.

Results: With the exception of lysine, methionine, glutamate, ornithine, phenylalanine, and tyrosine, plasma concentrations of amino acids were lower in the patients with sepsis than in the control subjects; phenylalanine was the only amino acid whose plasma concentration increased (P < 0.001). In patients with sepsis, whole-body clearance (Cl(tot)) of total amino acids was 74% higher than in control subjects (x +/- SEM: 13,161 +/- 1659 and 7566 +/- 91 mL/min, respectively; P < 0.01), the Cl(tot) of essential amino acids was 64% higher (P < 0.02), that of nonessential amino acids was 82% higher (P < 0.01), and that of both branched-chain amino acids and glucogenic amino acids was 97% higher (P < 0.001). With the exception of phenylalanine, ornithine, proline, and glutamate, the Cl(tot) of all amino acids was elevated. The Cl(tot) of phenylalanine and ornithine decreased slightly (NS).

Conclusions: In patients with sepsis, plasma concentrations of most amino acids are greatly decreased and the elimination of amino acids from the intravascular space during intravenous infusion is greatly enhanced.

Citing Articles

Development and internal validation of a metabolism-related model for predicting 30-day mortality in neonatal sepsis.

Tu X, Chen J, Liu W BMC Infect Dis. 2025; 25(1):121.

PMID: 39871138 PMC: 11771113. DOI: 10.1186/s12879-025-10527-z.


Alanine, a potential amino acid biomarker of pediatric sepsis: a pilot study in PICU.

Liu T, Xu Y, Hu S, Feng S, Zhang H, Zhu X Amino Acids. 2024; 56(1):48.

PMID: 39060743 PMC: 11281965. DOI: 10.1007/s00726-024-03408-3.


Improved Macro- and Micronutrient Supply for Favorable Growth and Metabolomic Profile with Standardized Parenteral Nutrition Solutions for Very Preterm Infants.

Kindt A, Kraus Y, Rasp D, Foerster K, Ahmidi N, Flemmer A Nutrients. 2022; 14(19).

PMID: 36235563 PMC: 9572167. DOI: 10.3390/nu14193912.


Dichloroacetate improves systemic energy balance and feeding behavior during sepsis.

Oh T, Zabalawi M, Jain S, Long D, Stacpoole P, McCall C JCI Insight. 2022; 7(12).

PMID: 35730570 PMC: 9309051. DOI: 10.1172/jci.insight.153944.


Past Experiences for Future Applications of Metabolomics in Critically Ill Patients with Sepsis and Septic Shocks.

Trongtrakul K, Thonusin C, Pothirat C, Chattipakorn S, Chattipakorn N Metabolites. 2022; 12(1).

PMID: 35050123 PMC: 8779293. DOI: 10.3390/metabo12010001.